Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.42 |
| ▸ | CCR8 | P51685 | 1/20 | 0.42 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29248288 | 0.77 | ADORA2A (0.44) | ADORA2AADORA1ADORA2BMEN1KMT2A | |
| SCHEMBL30421349 | 0.73 | — | — | |
| SCHEMBL9611 | 0.73 | — | — | |
| SCHEMBL1771685 | 0.73 | CCR1 (0.71) | CCR1CCR8NOS3NOS2MEN1 | |
| SCHEMBL1990834 | 0.73 | POLB (0.45) | CCR1NOS3NOS2ADORA2AADORA1 | |
| SCHEMBL3027281 | 0.72 | CCR1 (0.55) | CCR1CCR8NOS3NOS2MEN1 | |
| SCHEMBL21801276 | 0.71 | ACHE (0.39) | MEN1KMT2AKDM4ETDP1 | |
| SCHEMBL21880900 | 0.71 | ADORA2A (0.41) | NOS3NOS2ADORA2AADORA1ADORA2B | |
| SCHEMBL840279 | 0.70 | POLB (0.35) | NOS3NOS2ADORA2AADORA1ADORA2B | |
| SCHEMBL4546868 | 0.70 | ADORA2A (0.53) | ADORA2AADORA1ADORA2BMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10381579-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-08-13 | — | — | US | claimed |
| US-20150249225-A1 | STABILITY OLED MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-03 | — | — | US | claimed |
| US-9051344-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-09 | — | — | US | claimed |
| EP-1878053-B1 | STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORP (US) | 2009-08-26 | — | — | EP | claimed |
| US-11404650-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-08-02 | — | — | US | disclosed |
| US-10381579-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-08-13 | — | — | US | disclosed |
| US-20150249225-A1 | STABILITY OLED MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-03 | — | — | US | disclosed |
| CN-101180304-B | Stable OLED materials and devices with improved stability | UNIVERSAL DISPLAY CORP. (US) | 2015-08-19 | — | — | CN | disclosed |
| US-9051344-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-09 | — | — | US | disclosed |
| US-7902374-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2011-03-08 | — | — | US | disclosed |
| EP-1878053-B1 | STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORP (US) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008054584-A1 | IMPROVED STABILITY OLED MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2008-05-08 | — | — | WO | disclosed |
| EP-1878053-A1 | STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY | Universal Display Corporation (US) | 2008-01-16 | — | — | EP | disclosed |
| US-20070088167-A1 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION | 2007-04-19 | — | — | US | disclosed |
| WO-2006121811-A1 | STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORPORATION (US) | 2006-11-16 | — | — | WO | disclosed |
| US-20060251923-A1 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION | 2006-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11404650-B2 | Stability OLED materials and devices | OCIAD2, OCIAD1, OSBP2 | CCR1 2815/4885CCR8 2754/4885NOS3 3574/4885 |
| US-10381579-B2 | Stability OLED materials and devices | OCIAD2, OCIAD1, OSBP2 | CCR1 2883/4885CCR8 2791/4885NOS3 3584/4885 |
| US-20150249225-A1 | STABILITY OLED MATERIALS AND DEVICES | OCIAD2, OCIAD1, OSBP2 | CCR1 2883/4885CCR8 2791/4885NOS3 3584/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.